Industry

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the company will present new data that highlight the development of its highly selective, context-dependent TGFβ1 antibody that inhibits proTGFβ1 activation selectively in the context … [Read more…]

ISS Recommends Common Shareholders Vote in Favor of Proposals 1 and 2 Discussed Below ATLANTA–(BUSINESS WIRE)–Regional Health Properties, Inc. (NYSE American: RHE) (NYSE American: RHE-PA) (“RHE,” “we” or the “Company”) reminds its common shareholders to vote at the upcoming special meeting (the “Special Meeting”) to be held on Monday, July 25, 2022 at 10:00 a.m., … [Read more…]

EVANSTON, Ill.–(BUSINESS WIRE)–Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company will host a conference call and live webcast on Thursday, August 4, 2022 at 5:00 p.m. ET to report second quarter 2022 financial results and discuss recent business … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces record sales of Avenova-branded products during Amazon’s Prime Day event (July 12-13). Sales of Avenova-branded products during the two-day event increased 27% over Prime Days 2021 and 48% over Prime Days 2020, and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Elastase Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Elastase Inhibitor – Pipeline Insight, 2022” offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Elastase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules), by Mechanism (Controlled-, Immediate-release), by End-user, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global oral solid dosage contract manufacturing market size is expected to reach USD 54.7 billion … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Prefilled Syringes, Vials, Cartridges), by Molecule Type, by End-user, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global fill-finish pharmaceutical contract manufacturing market size is expected to reach USD 14.0 billion by … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Contract Research Outsourcing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. This report on the global healthcare contract research outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Medical Polyetheretherketone Market Size, Share & Trends Analysis Report by Application {Orthopedic (Spine Implantation, Knee & Hip Implantation), Cardiovascular}, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global medical polyetheretherketone market size is expected to reach USD 1.0 billion by 2030. It is expected to expand … [Read more…]

Revenues of $80.3 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Earnings from Operations were $7.1 Billion, Growth of 19% Year-Over-Year Cash Flows from Operations were $6.9 Billion, 1.3x Net Income Earnings were $5.34 Per Share, Adjusted Earnings $5.57 Per Share MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealth Group (NYSE: UNH) reported second quarter 2022 … [Read more…]